Venture Capital Investors

Pivotal bioVenture Partners

Pivotal bioVenture Partners makes VC investments in companies focused on high-impact, technology-driven solutions.

Venture Investor Overview

Venture Investor
Pivotal bioVenture Partners
Status
Active
Investor Type
Venture Capital
Activity Level
29 transactions
Funds Raised
At least $300 million
Industry Focus
Biopharmaceutical
Healthcare IT
Healthcare Services
Life Sciences

Contact Information

Contact
Tracy Saxton
Title
Managing Partner
Mailing Address
501 2nd St. 216
San Francisco, CA 94107
USA
Phone
(415) 697-1002
Website
www.pivotalbiovp.com
Email Address
[email protected]

Background Information

Overview
Pivotal bioVenture Partners is a San Francisco-based venture capital firm investing in early stage biotechnology companies. Pivotal closed on $300 million for their first fund and its investment strategy is centered on identifying companies developing differentiated science from discovery to early clinical development with the potential to deliver transformative therapies. The Pivotal team includes experienced life science investors and entrepreneurs with a track record of venture investing and scientific acumen.
Profile
Pivotal bioVenture Partners LinkedIn Company Profile
Social Media
Pivotal bioVenture Partners Company Twitter Account
Company News
Pivotal bioVenture Partners News
Facebook
Pivotal bioVenture Partners on Facebook
YouTube
Pivotal bioVenture Partners on YouTube
Last Transaction
2/13/2024

Transaction History

Our records indicate that Pivotal bioVenture Partners invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
BioAge Labs
2/13/2024
$170,000,000
Heranova Lifesciences
12/28/2023
$13,500,000
Avalyn Pharma
9/27/2023
$175,000,000
Evommune
4/26/2023
$50,000,000
Zenas BioPharma
11/8/2022
$118,000,000
Plexium
2/23/2022
$102,000,000
Arkuda Therapeutics
2/18/2022
$64,000,000
DermBiont
12/22/2021
$28,000,000
HotSpot Therapeutics
11/30/2021
$100,000,000
aptihealth
11/18/2021
$50,000,000
Obsidian Therapeutics
9/13/2021
$115,000,000
Vigil Neuroscience
8/19/2021
$90,000,000
Plexium
1/22/2021
$35,000,000
Bolt Biotherapeutics
7/2/2020
$93,500,000
Rallybio
5/20/2020
$145,000,000
Avalyn Pharma
4/29/2020
$35,500,000
SutroVax
3/27/2020
$110,000,000
Aligos Therapeutics
1/13/2020
$125,000,000
Oncologie
6/11/2019
$80,000,000
Inozyme Pharma
4/11/2019
$67,000,000
Fusion Pharmaceuticals
4/3/2019
$105,000,000
Karuna Therapeutics
4/2/2019
$12,000,000
Karuna Therapeutics
3/19/2019
$68,000,000
Bolt Biotherapeutics
2/6/2019
$54,000,000
Stealth BioTherapeutics
6/19/2018
$100,000,000
SutroVax
6/8/2018
$85,000,000
Oncologie
6/8/2018
$16,500,000
Iterum Therapeutics
5/20/2017
$65,000,000
SutroVax
3/22/2017
$64,000,000

 

Investor Contacts

Title
Name
Email & Social
Managing Partner
Peter Bisgaard
  Peter Bisgaard LinkedIn Profile  Peter Bisgaard Twitter Account  Peter Bisgaard News  Peter Bisgaard on Facebook
Managing Partner
Vincent Cheung
  Vincent Cheung LinkedIn Profile  Vincent Cheung Twitter Account  Vincent Cheung News  Vincent Cheung on Facebook
Managing Partner
Robert Hopfner
  Robert Hopfner LinkedIn Profile  Robert Hopfner Twitter Account  Robert Hopfner News  Robert Hopfner on Facebook
Partner
Ash Khanna
  Ash Khanna LinkedIn Profile  Ash Khanna Twitter Account  Ash Khanna News  Ash Khanna on Facebook
Partner
Karoly Nikolich
  Karoly Nikolich LinkedIn Profile  Karoly Nikolich Twitter Account  Karoly Nikolich News  Karoly Nikolich on Facebook
Managing Partner
Heather Preston
  Heather Preston LinkedIn Profile  Heather Preston Twitter Account  Heather Preston News  Heather Preston on Facebook

 

Funds

Our database includes the following fund closing(s) for Pivotal bioVenture Partners. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
Pivotal bioVenture Partners Fund I
3/16/2017
$300,000,000

 

Portfolio Companies

Pivotal bioVenture Partners has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Aligos Therapeutics
aptihealth
Arkuda Therapeutics
Avalyn Pharma
BioAge Labs
Bolt Biotherapeutics
DermBiont
Evommune
Fusion Pharmaceuticals
Heranova Lifesciences
HotSpot Therapeutics
Inozyme Pharma
Iterum Therapeutics
Karuna Therapeutics
Obsidian Therapeutics
Oncologie
Plexium
Rallybio
Stealth BioTherapeutics
SutroVax
Vigil Neuroscience
Zenas BioPharma

 

 

 

 

Browse more venture capital investors:

Pivotal Alpha | Pivotal Group

 

Share this article

 

About Our VC Investors Database

This venture capital firm data comes via a partnership with VentureDeal.com, a leading supplier of venture capital funding data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.